| |
Supplying
Strength: Millennium Biotechnologies Group Inc. (OTCBB:MBTG)
By Glenn Wilkins -
AllPennyStocks.com News Reporter
February 6, 2008 (AllPennyStocks.com
Media, Inc.) – The aim of every physician is not merely to
prolong life but to make it more whole, more bearable, and
more livable. With advances in science enabling doctors and
their patients to do all of that, one wave of the future for
investors originates out of the realm of new medicines to
boost the quality of life for everyone. One firm hoping to
make a big splash in this pond is Millennium Biotechnologies
Group
(OTCBB:MBTG), a company located in Basking Ridge, New
Jersey.
The Company's currently marketed products are targeted toward
immuno-compromised individuals undergoing medical treatment
for diseases, such as cancer, as well as individuals living
with HIV/ AIDS and wound healing and post-surgical healing,
among other conditions.
Millennium’s standard-bearer, however, remains
Resurgex Select, a comprehensive high-protein, high-calorie,
whole-foods-based nutritional formula, designed to provide
essential high-quality nutrients to chronically ill patients,
particularly those undergoing cancer treatments.
Industry sources report the market for nutritional supplements
rang in at $4.7 billion (all figures in U.S. funds unless
specified otherwise) at the end of 2006, a figure projected to
shoot up to $6 billion.
Millennium has received Medicaid and Medicare approval for the
Resurgex® line of products in Connecticut, Michigan, Nevada,
New York, Pennsylvania, and of course, its native New Jersey.
Millennium has also recently developed a Surgex® sports
nutrition formula, clinically proven to address the
nutritional concerns of both professional and amateur elite
athletes, to combat fatigue, loss of lean muscle, oxidative
stress, and reduced immune function. Over the past few weeks,
Surgex was announced as part of the nutritional program
provided to elite Division I & II Collegiate Football athletes
training for the NFL Combine at TEST Sports Clubs™ in
Martinsville, New Jersey.
In fact, during the NBA 2005-2006 season, several clubs
purchased Resurgex® and or Resurgex® Plus and had players
using the products before and after practices, games and
training sessions.
Various Medical studies seem to back the Company’s products,
one of which was performed when Millennium conducted two
double-blind placebo-controlled clinical trials at Rutgers
University with Resurgex among the school’s Men's Division I
Soccer and Football teams. These studies demonstrated the
product's beneficial effects as a post-workout recovery and
strength aid versus a leading sports formula, assisting the
athlete in recovery parameters that result in improved
performance.
In January of 08, Surgex was certified into the Banned
Substance Control Group's (BSCG) certification program. This
is the only certification program in the U.S. that uses a
World Anti Doping Agency accredited laboratory to detect for
dangerous banned substances in nutritional supplements.
Each batch of Millennium's line of Surgex products is now
tested and certified not to contain substances such as
hormones, steroids, stimulants, diuretics, etc. that are
banned for professional, collegiate and Olympic sports.
Millennium hopes to start marketing Surgex in the third
quarter of this fiscal year.
On the investment front, Millennium succeeded early this year
in securing $600,000 (all figures in U.S. funds unless
specified otherwise) in product development funding with
Cleveland-based Provider Services. The pact will have MBTG
working with Provider, Ohio’s second-largest Long Term Care
services provider, currently with more than 12,000 residents
in its homes.
Millennium President Mark Mirken commented, “our agreement
will allow us to use Millennium’s extensive clinical
experience and success in the cancer and HIV channels and
apply that experience to the nutritional challenges in the
Long-Term care channel.”
The Company has recently partnered with P4 Healthcare, LLC to
promote its products to hundreds of private oncology
practices, providing Millennium with exclusive access to
www.caring4cancer.com, a primary source of cancer information
for more than 1.2 million cancer patients annually.
The Company has also elected to focus its marketing efforts
through the medical community, through a pharmaceutical sales
approach and distribution model, believing that model to be
more credible than the approach taken by the bigger
competitive brands. The Company’s marketing plan, once it is
launched, will likely be aimed at pro and amateur sports
organizations.
In terms of the company’s bottom line, administrative costs
associated with research and development have courted the $2
million mark, resulting in losses near $3 million in the
quarter ending in September 2007.
To what should be no one’s surprise, the stock price is around
the dime mark to begin 2008, something of a low for the last
52 weeks. But even at its 52-week peak, back in June, MBTG
could be had for as little as 24 cents. But with the Company’s
credibility, and the inroads it’s made with major sports
organizations, investors should look for Millennium
Biotechnologies to keep making waves in the nutritional
supplement market.
Copyright © 2008 AllPennyStocks.com. All
rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without
the prior written consent of AllPennyStocks.com.
AllPennyStocks.com shall not be liable for any errors or
delays in the content, or for any actions taken in reliance
thereon.
Although the majority of
AllPennyStocks.com reports are independent, it has received
compensation for carrying the report on Millennium
Biotechnologies Group, Inc., the compensation is sixteen
thousand dollars by a non-affiliated third-party, Shah and
Associates LLC. for its efforts in presenting the MBTG profile
on its web site and distributing it to its database of
subscribers as well as other services. This creates an inherent
conflict of interest and readers are encouraged to view the
main disclaimer at
/aps_us/company_spotlights/archives/mbtg.asp
|
|
